Action of ondansetron and CP-99,994 on cisplatin-induced emesis and locomotor activity in Suncus murinus (house musk shrew)

Behavioural Pharmacology

Volumn 16, Issue 8, 2005, Pages 605-612

  Lau, Angie H Y ^a   Rudd, John A ^a,b   Yew, David T W ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

5 HT3 receptor; Anti emetic; Cisplatin; Emesis; House musk shrew; Locomotor; Nausea; NK1 receptor; Suncus murinus

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; CISPLATIN; ONDANSETRON;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; INSECTIVORE; LOCOMOTION; NAUSEA; NONHUMAN; SUNCUS MURINUS; VOMITING;

ANIMALS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; CISPLATIN; FEMALE; MOTOR ACTIVITY; ONDANSETRON; PIPERIDINES; SEROTONIN AGONISTS; SHREWS; VOMITING;

EID: 27944452623     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200512000-00002     Document Type: Article

References (40)

1. 1 receptor in nausea and emesis. In: Holzer P, editor. Handbook of experimental pharmacology. Vol. 164. New York: Springer; pp. 359-441.
2. Andrews PLR, Dovey E, Hockaday J, Hoyle CH, Woods AJ, Matsuki N (2000). The development of the emetic reflex in the house musk shrew, Suncus murinus. Brain Res Devel Brain Res 121:29-34.
3. 3 receptor antagonist BRL 43694. Br J Cancer 58:644-650.
4. 1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res 915:170-175.
5. Daunton NG (2000). Animal models in motion sickness research. In: Crampton GH, editor. Motion and space sickness. Boca Raton: CRC Press Inc.; pp. 87-104.
6. Fox RA (1992). Current status: animal models of nausea. In: Bianchi AL, Grélot L, Miller AD, King GL, editors. Mechanisms and control of emesis. Vol. 223. Paris: Inserm/John Libbey Eurotext; pp. 341-350.
7. 1 receptor antagonist GR203040. Br J Pharmacol 116:3158-3163.
8. 1 receptor, and potent broad-spectrum anti-emetic activity. Reg Peptides 65:45-53.
9. 3 receptor antagonist on cyclophosphamide induced vomiting in the ferret. Br J Cancer 61:56-60.
10. 3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting. Cancer Invest 18:163-173.
11. Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, et al. (2003). Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39:1074-1080.
12. Hunt T, Amit Z (1987). Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci Biobehav Rev 11:107-130.
13. Kent S, Bluthe RM, Kelley KW, Dantzer R (1992). Sickness behaviour as a new target for drug development. Trends Pharmacol Sci 13:24-28.
14. 3) receptor antagonist zacopride in the ferret. J Pharmacol Exp Ther 253:1034-1041.
15. Konsman JP, Parnet P, Dantzer R (2002). Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25:154-159.
16. Lau AHY, Kan KKW, Lai HW, Ngan MP, Rudd JA, Wai MK, et al. (2005a). Action of ondansetron and CP-99,994 to modify behaviour and antagonize cisplatin-induced emesis. Eur J Pharmacol 506:241-247.
17. Lau AHY, Rudd JA, Yew DTW (2005b). Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret. Eur J Pharmacol 516:247-252.
18. Liu Y-L, Malik N, Sanger GJ, Friedman MI, Andrews PLR (2005). Pica: a model of nausea? Species differences in response to cisplatin. Physiol Behav 85:271-277.
19. Lucot JB, Obach RS, McLean S, Watson JW (1997). The effect of CP-99994 on the responses to provocative motion in the cat. Br J Pharmacol 120:116-120.
20. Matsuki N, Wang CH, Okada F, Tamura M, Ikegaya Y, Lin SC, et al. (1997). Male/ female differences in drug-induced emesis and motion sickness in Suncus murinus. Pharmacol Biochem Behav 57:721-725.
21. Mclean S, Ganong A, Seymour PA, Snider RM, Desai MC, Rosen T, et al. (1993). Pharmacology of CP-99,994: a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther 267:472-479.
22. Milano S, Blower P, Romain D, Grélot L (1995). The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis. J Pharmacol Exp Ther 274:951-961.
23. Naylor RJ, Rudd JA (1994). Emesis and anti-emesis. Cancer Surveys 21:117-135.
24. Parker LA, Kemp SW (2001). Tetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus: an animal model of anticipatory nausea and vomiting (ANV). Neuroreport 12:749-751.
25. Parker LA, Corrick ML, Limebeer CL, Kwiatkowska M (2002). Amphetamine and morphine produce a conditioned taste and place preference in the house musk shrew (Suncus murinus). J Exp Psychol Anim Behav Process 28:75-82.
26. Parker LA, Kwiatkowska M, Burton P, Mechoulam R (2004). Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology 171:156-161.
27. 3 receptor antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. Br J Clin Pharmacol 50:61-64.
28. Rudd JA, Andrews PLR (2004). Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In: Hesketh PJ, editor. Management of nausea and vomiting in cancer and cancer treatment. London: Jones and Barlett Publishers Inc.; pp. 15-66.
29. 3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin. Eur J Pharmacol 352:143-149.
30. 1 receptor antagonists in Suncus murinus (house musk shrew). Eur J Pharmacol 366:243-252.
31. 3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur J Pharmacol 472:135-145.
32. Schiml PA, Douris N, Isaac AC, Rissman EF (1999). Temporal aspects of female musk shrew (Suncus murinus) sexual behavior. J Comp Psychol 113:85-90.
33. Smith JE, Friedman MI, Andrews PLR (2001). Conditioned food aversion in Suncus murinus (house musk shrew): a new model for the study of nausea in a species with an emetic reflex. Physiol Behav 73:593-598.
34. Suri KB, Crampton GH, Daunton NG (1995). Motion sickness in cats: a symptom rating scale used in laboratory and flight tests. Aviat Space Environ Med 50:614-618.
35. 3 receptor antagonists in Suncus murinus. Jpn J Pharmacol 55:107-113.
36. Ueno S, Matsuki N, Saito H (1987). Suncus murinus: a new experimental model in emesis research. Life Sci 41:513-518.
37. 3 receptor antagonist, reduces palatable food consumption in the nondeprived rat. Neuropharmacol 33:805-811.
38. 3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze. Psychopharmacol 110:213-218.
39. 1 receptor. Br J Pharmacol 115:84-94.
40. Yamamoto K, Ngan MP, Takeda N, Yamatodani A, Rudd JA (2004). Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats. Physiol Behav 83:151-156.